AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN
Authors: KOREN MJ SMITH DG HUNNINGHAKE DB DAVIDSON MH MCKENNEY JM WEISS SR SCHROTT HG HENLEY RW TRESH P MCLAIN RW BAKKERARKEMA RG BLACK DM
Citation: Mj. Koren et al., THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN, PharmacoEconomics, 14(1), 1998, pp. 59-70
ASCORBIC-ACID SUPPLEMENT USE AND THE PREVALENCE OF GALLBLADDER-DISEASE
Authors: SIMON JA GRADY D SNABES MC FONG J HUNNINGHAKE DB
Citation: Ja. Simon et al., ASCORBIC-ACID SUPPLEMENT USE AND THE PREVALENCE OF GALLBLADDER-DISEASE, Journal of clinical epidemiology, 51(3), 1998, pp. 257-265
DELAYED PROGRESSION OF ATHEROSCLEROSIS IN CORONARY-BYPASS GRAFTS IS SIMILAR IN WOMEN COMPARED TO MEN FOLLOWING AGGRESSIVE CHOLESTEROL-LOWERING DESPITE MORE FREQUENT RISK-FACTORS - POST CABG TRIAL
Authors: CAMPEAU L KNATTERUD G DOMANSKI M FORRESTER JS GELLER N GOBEL F HERD JA HOOGWERF B HUNNINGHAKE DB WHITE C ROSENBERG Y
Citation: L. Campeau et al., DELAYED PROGRESSION OF ATHEROSCLEROSIS IN CORONARY-BYPASS GRAFTS IS SIMILAR IN WOMEN COMPARED TO MEN FOLLOWING AGGRESSIVE CHOLESTEROL-LOWERING DESPITE MORE FREQUENT RISK-FACTORS - POST CABG TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 280-281
CLINICAL EFFICACY OF CERIVASTATIN - PHASE IIA DOSE-RANGING AND DOSE-SCHEDULING STUDIES
Authors: HUNNINGHAKE DB
Citation: Db. Hunninghake, CLINICAL EFFICACY OF CERIVASTATIN - PHASE IIA DOSE-RANGING AND DOSE-SCHEDULING STUDIES, The American journal of cardiology, 82(4B), 1998, pp. 26-31
CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/
Authors: DAVIGNON J HANEFELD M NAKAYA N HUNNINGHAKE DB INSULL W OSE L
Citation: J. Davignon et al., CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/, The American journal of cardiology, 82(4B), 1998, pp. 32-39
REVIEW OF THE NIH POST-CABG STUDY AND FUTURE ADVANCES IN HMG-COA THERAPY
Authors: HUNNINGHAKE DB
Citation: Db. Hunninghake, REVIEW OF THE NIH POST-CABG STUDY AND FUTURE ADVANCES IN HMG-COA THERAPY, American journal of managed care, 3, 1997, pp. 14-17
EFFECT OF CILOSTAZOL ON PLASMA-LIPOPROTEINS IN PATIENTS WITH INTERMITTENT CLAUDICATION
Authors: ELAM MB HECKMAN J CROUSE JR HUNNINGHAKE DB HERD JA DAVIDSON M FORBES W
Citation: Mb. Elam et al., EFFECT OF CILOSTAZOL ON PLASMA-LIPOPROTEINS IN PATIENTS WITH INTERMITTENT CLAUDICATION, Journal of the American College of Cardiology, 29(2), 1997, pp. 7253-7253
DMP-504, A NOVEL HYDROGEL BILE-ACID SEQUESTRANT - III - SAFETY, TOLERABILITY, AND CHOLESTEROL-LOWERING IN HEALTHY HYPERCHOLESTEROLEMIC SUBJECTS
Authors: HAINER JW HUNNINGHAKE DB BENEDEK IH BROYLES FE GARNER DM JENKINS RM MCGINN A PIENIASZEK HJ LONDON E GILLIES PJ
Citation: Jw. Hainer et al., DMP-504, A NOVEL HYDROGEL BILE-ACID SEQUESTRANT - III - SAFETY, TOLERABILITY, AND CHOLESTEROL-LOWERING IN HEALTHY HYPERCHOLESTEROLEMIC SUBJECTS, Drug development research, 41(2), 1997, pp. 76-84
RECRUITMENT FOR CONTROLLED CLINICAL-TRIALS - LITERATURE SUMMARY AND ANNOTATED-BIBLIOGRAPHY
Authors: LOVATO LC HILL K HERTERT S HUNNINGHAKE DB PROBSTFIELD JL
Citation: Lc. Lovato et al., RECRUITMENT FOR CONTROLLED CLINICAL-TRIALS - LITERATURE SUMMARY AND ANNOTATED-BIBLIOGRAPHY, Controlled clinical trials, 18(4), 1997, pp. 328-352
THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS
Authors: CAMPEAU L KNATTERUD GLMK DOMANSKI M HUNNINGHAKE DB WHITE CW GELLER NL ROSENBERG Y HERD A COCANOUGHER MK DUNN K FARMER J FOREYT J GREGORY K INSULL W JACKSON M KLEIMAN N LEWIS R LLOYD C MARESH K MATTHEW C MINOR S ROBERTS R SALMON A SHACKELFORD P STEWART R THOMPSON M YOUNG J GUINN A HARRIS G HEIBIG J LEVY VV FORRESTER J HICKEY A BUCHBINDER N DAVIDSON R DRURY K EBER L EIGLER N GEFT I GOLDBERG S GRODAN P HENDEL J HIGGINS S HODGSON T HUGHES L KARLSBERG R KATZ J LEPOR N LITVAK F LUPTAK Y MADERA G MARCUS H MONDKAR A NEIDORF B NEUMANN M NIVATPUMIN T RABINOWITZ Y RAYMOND M READER A RURYCZ V SCHAPIRA J SCHLANGER J SILVERBERG R SMITH A TABAK S VALOVIS R GRAY R HOOGWERF B STEWART W BAERVEDT G BOTTSILVERMAN C BREEN C BUCKNER P CABRAL J CRESSMAN M FONSECA C FOSTER J FOSTER R GUTMAN F HARRIS L HEUPLER F HOBBS R HUANG S KALENAK J KASSEM M KOSMORSKY G KRAMER J KURZAWA C LANGSTON R LINCOFF M LINDBERG J LOWDER C MCCAFFERTY F MCKEOWN D MEISLER D MENDLOVIC D MEYERS S MOORE J NOUSEK J RAYMOND R RINCON G ROBIN J ROCKWOOD E SHELDON W SIMPFENDORFER C WALSH H WANESS A WRIGHT K YANAK F GOULET C BEDARD H BOIS M BUJOLD S COTE G DAVIGNON J DEBELDER M DUCHARME AM DOUCET S DUMAS J DYDRA I FOUCHER S CREPEAU J GOSSELIN G GROULX D JOYAL M JUNEAU M LESPERANCE J LEVESQUE C LEVESQUE J MARCIL M OLIVIER M PASTERNAC A POITRAS AM POITRAS D QUEVILLON A RIOUX C ROBITAILLE D SISOUPHONE K SOLYMOSS C HUNNINGHAKE D CHRISTIANSON B DIANGELIS N GARDNER K HELGREN R IACARELLA C KNOBLOCH W LAU L LAXSON D LEON A LONDON E MANION R MCDONALD K MCGINN A MIANULLI M ROBINSON J TURNER G WANG Y WHITE C WILSON R ZIMMER S GOBEL F ANDERSON P BAUMGARD C CHRISTENSEN J FULCO A HANSON K JOHNSON C LARSON B MADISON J MCCORMACK P OSTROV C PECHA R PEDERSON W PIER T RANDALL M RODMAN W ROELLER S SCOTT K SHER N SPEILMAN J THOMPSON R ZUPFER S GOLDENBERG I HEALY B KNATTERUD G TERRIN M CANNER M FICK S FORMAN S HANSON D HOWARD J HUANG AL KARABELAS S LOPRESTI F MERCER W RA K RANDALL A SCHACTMAN M SCHLEIGH B SNIDER R MIRENZI E FISHER M FOX NL CZAJKOWSKI S GELLER N PROBSTFIELD J SHUMAKER S WITTES J YUSUF S ZUCKER D CARTLAND J DAS G MEYER S POWERS T RINGDAL D ROSZA Z SHAHEEN B SIREK M STONE C SNIDER J VANYI J ALAUPOVIC P FESMIRE J WALENGA J BERMES E HOPPENSTEADT D PIFARRE R CARLETON R BAILEY K BRODY B CAIRNS J FURBERG C FUSTER V GRONDIN C JENKINS D LAROSA J MEIER P
Citation: L. Campeau et al., THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS, The New England journal of medicine, 336(3), 1997, pp. 153-162
PREVENTION OF ATHEROSCLEROSIS IN CORONARY-ARTERY BYPASS GRAFTS - REPLY
Authors: CAMPEAU L KNATTERUD GL DOMANSKI M HUNNINGHAKE DB
Citation: L. Campeau et al., PREVENTION OF ATHEROSCLEROSIS IN CORONARY-ARTERY BYPASS GRAFTS - REPLY, The New England journal of medicine, 336(25), 1997, pp. 1839-1840
PSYLLIUM-ENRICHED CEREALS LOWER BLOOD TOTAL CHOLESTEROL AND LDL CHOLESTEROL, BUT NOT HDL CHOLESTEROL, IN HYPERCHOLESTEROLEMIC ADULTS - RESULTS EF A METAANALYSIS
Authors: OLSON BH ANDERSON SM BECKER MP ANDERSON JW HUNNINGHAKE DB JENKINS DJA LAROSA JC RIPPE JM ROBERTS DCK STOY DB SUMMERBELL CD TRUSWELL AS WOLEVER TMS MORRIS DH FULGONI VL
Citation: Bh. Olson et al., PSYLLIUM-ENRICHED CEREALS LOWER BLOOD TOTAL CHOLESTEROL AND LDL CHOLESTEROL, BUT NOT HDL CHOLESTEROL, IN HYPERCHOLESTEROLEMIC ADULTS - RESULTS EF A METAANALYSIS, The Journal of nutrition, 127(10), 1997, pp. 1973-1980
TARGETING HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLEMIA - THE EFFICACYAND SAFETY OF SIMVASTATIN 80 MG D/
Authors: HUNNINGHAKE DB
Citation: Db. Hunninghake, TARGETING HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLEMIA - THE EFFICACYAND SAFETY OF SIMVASTATIN 80 MG D/, Atherosclerosis, 134(1-2), 1997, pp. 125-126
RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE RANDOMIZED EVALUATION OF THE VASCULAR EFFECTS OF NORVASC TRIAL (PREVENT)
Authors: BYINGTON RP MILLER ME HERRINGTON D RILEY W PITT B FURBERG CD HUNNINGHAKE DB MANCINI GBJ
Citation: Rp. Byington et al., RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE RANDOMIZED EVALUATION OF THE VASCULAR EFFECTS OF NORVASC TRIAL (PREVENT), The American journal of cardiology, 80(8), 1997, pp. 1087
THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/
Authors: DAVIDSON MH STEIN EA DUJOVNE CA HUNNINGHAKE DB WEISS SR KNOPP RH ILLINGWORTH DR MITCHEL YB MELINO MR ZUPKIS RV DOBRINSKA MR AMIN RD TOBERT JA
Citation: Mh. Davidson et al., THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/, The American journal of cardiology, 79(1), 1997, pp. 38-42
EFFECT OF PHARMACOLOGICAL LIPID-LOWERING ON HEALTH-RELATED QUALITY-OF-LIFE IN OLDER PERSONS - RESULTS FROM THE CHOLESTEROL REDUCTION IN SENIORS PROGRAM (CRISP) PILOT-STUDY
Authors: SANTANELLO NC BARBER BL APPLEGATE WB ELAM J CURTIS C HUNNINGHAKE DB GORDON DJ
Citation: Nc. Santanello et al., EFFECT OF PHARMACOLOGICAL LIPID-LOWERING ON HEALTH-RELATED QUALITY-OF-LIFE IN OLDER PERSONS - RESULTS FROM THE CHOLESTEROL REDUCTION IN SENIORS PROGRAM (CRISP) PILOT-STUDY, Journal of the American Geriatrics Society, 45(1), 1997, pp. 8-14
TASK-FORCE 4 - EFFICACY OF RISK FACTOR MANAGEMENT
Authors: FORRESTER JS MERZ CNB BUSH TL COHN JN HUNNINGHAKE DB PARTHASARATHY S SUPERKO HR
Citation: Js. Forrester et al., TASK-FORCE 4 - EFFICACY OF RISK FACTOR MANAGEMENT, Journal of the American College of Cardiology, 27(5), 1996, pp. 991-1006
NIACIN LOWERS FIBRINOGEN IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
Authors: CHESNEY CM HERD JA ELAM MB GARG R DAVIS KB KENNEDY JW HUNNINGHAKE DB APPLEGATE WB
Citation: Cm. Chesney et al., NIACIN LOWERS FIBRINOGEN IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD), Circulation, 94(8), 1996, pp. 3419-3419
CORRELATION OF RISK-FACTORS WITH SEVERITY OF LOWER-EXTREMITY VASCULAR-DISEASE IN THE ATHEROSCLEROTIC DISEASE MULTIPLE INTERVENTION TRIAL (ADMIT) - INFLUENCE OF SEX AND RACE
Authors: ELAM MB SMITH MD YOUNG MZ GRANEY MJ CHESNEY CM GARG R EGAN DA PETTINGER MB DAVIS KB HUNNINGHAKE DB CROUSE JR HERD JA KOSTIS JB SHEPS DS APPLEGATE WB
Citation: Mb. Elam et al., CORRELATION OF RISK-FACTORS WITH SEVERITY OF LOWER-EXTREMITY VASCULAR-DISEASE IN THE ATHEROSCLEROTIC DISEASE MULTIPLE INTERVENTION TRIAL (ADMIT) - INFLUENCE OF SEX AND RACE, Circulation, 92(8), 1995, pp. 488-488
EFFECT OF FLUVASTATIN ON INTERMEDIATE DENSITY LIPOPROTEIN (REMNANTS) AND OTHER LIPOPROTEIN LEVELS IN HYPERCHOLESTEROLEMIA
Authors: BROYLES FE WALDEN CE HUNNINGHAKE DB HILLWILLIAMS D KNOPP RH
Citation: Fe. Broyles et al., EFFECT OF FLUVASTATIN ON INTERMEDIATE DENSITY LIPOPROTEIN (REMNANTS) AND OTHER LIPOPROTEIN LEVELS IN HYPERCHOLESTEROLEMIA, The American journal of cardiology, 76(2), 1995, pp. 129-135
HYPERLIPIDEMIA IN LONG-TERM SURVIVORS OF PEDIATRIC RENAL-TRANSPLANTATION
Authors: SHARMA AK MYERS TA HUNNINGHAKE DB MATAS AJ KASHTAN CE
Citation: Ak. Sharma et al., HYPERLIPIDEMIA IN LONG-TERM SURVIVORS OF PEDIATRIC RENAL-TRANSPLANTATION, Clinical transplantation, 8(3), 1994, pp. 252-257
DIAGNOSIS AND TREATMENT OF LIPID DISORDERS
Authors: HUNNINGHAKE DB
Citation: Db. Hunninghake, DIAGNOSIS AND TREATMENT OF LIPID DISORDERS, The Medical clinics of North America, 78(1), 1994, pp. 247-257
LIPID DISORDERS - PREFACE
Authors: HUNNINGHAKE DB
Citation: Db. Hunninghake, LIPID DISORDERS - PREFACE, The Medical clinics of North America, 78(1), 1994, pp. 180000011-180000012
CHANGES IN COMPOSITION AND DISTRIBUTION OF LDL SUBSPECIES IN HYPERTRIGLYCERIDEMIC AND HYPERCHOLESTEROLEMIC PATIENTS DURING GEMFIBROZIL THERAPY
Authors: YUAN JN TSAI MY HUNNINGHAKE DB
Citation: Jn. Yuan et al., CHANGES IN COMPOSITION AND DISTRIBUTION OF LDL SUBSPECIES IN HYPERTRIGLYCERIDEMIC AND HYPERCHOLESTEROLEMIC PATIENTS DURING GEMFIBROZIL THERAPY, Atherosclerosis, 110(1), 1994, pp. 1-11
EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS
Authors: FURBERG CD ADAMS HP APPLEGATE WB BYINGTON RP ESPELAND MA HARTWELL T HUNNINGHAKE DB LEFKOWITZ DS PROBSTFIELD J RILEY WA YOUNG B
Citation: Cd. Furberg et al., EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS, Circulation, 90(4), 1994, pp. 1679-1687
Risultati: 1-25 | 26-42